(c) 2024 PillSync.com

sacubitril 24 MG valsartan 26 MG Oral Tablet Entresto

1 INDICATIONS AND USAGE ENTRESTO is indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal. ( 1.1 ) for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. ENTRESTO reduces NT-proBNP and is expected to improve cardiovascular outcomes. ( 1.2 ) 1.1 Adult Heart Failure ENTRESTO is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal. LVEF is a variable measure, so use clinical judgment in deciding whom to treat [see Clinical Studies (14.1)] . 1.2 Pediatric Heart Failure ENTRESTO is indicated for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older. ENTRESTO reduces NT-proBNP and is expected to improve cardiovascular outcomes.

novartis pharmaceuticals corporation


2 years ago OVAL WHITE NVR LZ sacubitril 24 MG  valsartan 26 MG Oral Tablet Entresto

OVAL WHITE NVR LZ

2 years ago OVAL WHITE NVR LZ sacubitril 24 MG  valsartan 26 MG Oral Tablet Entresto

NVR LZ OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING ENTRESTO (sacubitril/valsartan) is available as unscored, ovaloid, biconvex, film-coated tablets, containing 24 mg of sacubitril and 26 mg of valsartan; 49 mg of sacubitril and 51 mg of valsartan; and 97 mg of sacubitril and 103 mg of valsartan. All strengths are packaged in bottles as described below. Tablet Color Debossment NDC # 0078-XXXX-XX Sacubitril/Valsartan “NVR” and Bottle of 60 Bottle of 180 24 mg/26 mg violet white LZ 0659-20 0659-67 49 mg/51 mg Pale yellow L1 0777-20 0777-67 97 mg/103 mg Light pink L11 0696-20 0696-67 Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Protect from moisture.


More pills like OVAL NVR LZ

Related Pills

sacubitril 24 MG valsartan 26 MG Oral Tablet Entresto

novartis pharmaceuticals corporation

sacubitril 24 MG valsartan 26 MG Oral Tablet Entresto

novartis pharmaceuticals corporation












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site